Previous Article | Next Article ![]()
Journal of Virology, February 2001, p. 1220-1228, Vol. 75, No. 3
Department of Molecular Virology and
Microbiology1 and Department of
Immunology,2 Baylor College of Medicine,
Houston, Texas 77030
Received 15 May 2000/Accepted 3 November 2000
Cdk9 is the catalytic subunit of TAK (cyclinT1/P-TEFb), a cellular
protein kinase that mediates human immunodeficiency virus type 1 (HIV-1) Tat transcriptional activation function. To examine Cdk9
function in cells relevant to HIV-1 infection, we used a murine
leukemia virus retrovirus vector to transduce and overexpress the cDNA
of a dominant negative mutant Cdk9 protein (Cdk9-dn) in Jurkat T cells
and U937 promonocytic cells. In Jurkat cells, overexpression of Cdk9-dn
specifically inhibited Tat transactivation and HIV-1 replication but
had no inhibitory effect on induction of CD69, CD25, and interleukin-2
following T-cell activation. In U937 cells, overexpression of Cdk9-dn
sensitized cells to apoptosis, especially after phorbol myristate
acetate (PMA) treatment to induce differentiation to macrophage-like
cells. Because Cdk9 function is induced in PMA-treated U937 cells, Cdk9
may play an antiapoptotic role during monocyte differentiation.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1220-1228.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937
Promonocytic Cells
*
Corresponding author. Mailing address: Department of
Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM-385, Houston, TX 77030. Phone: (713) 798-5774. Fax: (713) 798-3490. E-mail:
arice{at}bcm.tmc.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|